Super Vision Technology’s i-NYS Implantable Device Approved in China, Breaking the Treatment Barrier for Congenital Nystagmus
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) — A groundbreaking advancement in ophthalmology has been achieved as Super Vision Technology announced that its i-NYS (Extraocular Neuromuscular Stimulator Implant), the world’s first implantable treatment device for congenital nystagmus, has received market approval from the National Medical Products Administration (NMPA). The device has been officially authorized for…